News

Regen BioPharma, Inc. Engages Investors at Growth Conference

Regen BioPharma, Inc. Engages Investors at Growth Conference

Regen BioPharma, Inc. to Present at the Emerging Growth Conference

Regen BioPharma, Inc. is inviting both individual and institutional investors, as well as advisors and analysts, to join them for an interactive presentation at the upcoming Emerging Growth Conference.

Engagement Opportunities Await

On the virtual stage, Regen BioPharma, Inc. (OTC PINK: RGBP) will showcase its promising biotechnology projects. The company is well-regarded for its diverse pipeline, which includes cell therapies, RNA vaccines, RNA and DNA therapeutics, and small molecule drugs. This highly anticipated event is set for September 25.

Connect with Dr. David Koos

This engaging online event provides shareholders and interested investors the chance to interact directly with the company’s CEO, Dr. David Koos. Attendees will be encouraged to ask questions during the presentation, and the team will work to answer them promptly.

Updates on Goals and Progress

Dr. David Koos, CEO and Chairman, shared, "We intend to use this time to update our shareholders on our fiscal and scientific goals for the coming year, provide insights into our current programs, and discuss timelines for the anticipated HemaXellerate clinical phase I." This personal touch demonstrates the company's commitment to transparency and open communication.

Event Schedule

Mark your calendar: the Regen BioPharma presentation is scheduled for 4:00 PM to 4:10 PM Eastern Time on the day of the event. If you’d like to attend, be sure to register in advance to catch all the important updates.

Access to Archived Webcast

If you can’t attend live, don’t worry—an archived version of the presentation will be available on EmergingGrowth.com, so everyone can stay informed.

What is the Emerging Growth Conference?

The Emerging Growth Conference offers a critical platform for public companies to present their products, services, and key announcements to the investment community. It provides an efficient way for companies to connect with potential investors directly from their offices, simplifying the communication process.

Focusing on Growth Sectors

This conference highlights a range of growth sectors, shining a light on companies with strong management teams, innovative products, and a clear strategy for long-term growth. The audience is expected to include many individual and institutional investors, along with investment advisors and analysts.

About Regen BioPharma

Regen BioPharma, Inc. is a respected biotechnology firm (PINK: RGBP and PINK: RGBPP) dedicated to advancing the fields of immunology and immunotherapy. The company aims to rapidly advance its cutting-edge technologies through pre-clinical and Phase I/II clinical trials. With a focus on mRNA and small molecule therapies, Regen BioPharma is committed to addressing cancer and autoimmune disorders effectively.

Why Invest in Regen BioPharma?

Investors have the opportunity to delve into the exciting potential of Regen BioPharma's research and development initiatives, which reflect their dedication to significantly advancing healthcare solutions.

For further inquiries, please reach out using the contact details below:

Regen BioPharma Inc.
David R. Koos, Ph.D.
Chairman & Chief Executive Officer
Phone: +1-619-722-5505
Fax: +1-619-330-2328
Email: david.koos@regenbiopharma.com

Follow us on social media: X (formerly Twitter): https://x.com/TheRegenBio

Frequently Asked Questions

What is the Emerging Growth Conference?

The Emerging Growth Conference is a virtual space where companies can showcase their innovations and key announcements to investors.

How can I join the Regen BioPharma presentation?

Those interested should register ahead of time to participate and submit their questions during the live session.

What areas does Regen BioPharma focus on?

The company emphasizes immunology and immunotherapy, particularly in developing mRNA therapies aimed at treating cancer and autoimmune disorders.

Is a recording of the presentation available?

Yes, an archived version of the presentation will be accessible on EmergingGrowth.com for anyone unable to attend live.

Who can I contact at Regen BioPharma for more information?

If you have questions, you can contact David R. Koos via phone or email as provided in the article.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Lear Gears Up for Goldman Sachs Event Spotlight

Updated Category News Views 132

Lear Prepares for the Big Stage in London Autumn leaves and industry insights are falling in full swing as Lear Corporation gets its ducks in a row for the upcoming Goldman Sachs 18th Annual Industrials & Autos Week. Kicking off on December 3, 2026, this gathering in London isn't just another checkbox on their corporate calendar—it's a prime moment in the spotlight....

Continue Reading
Ranger and Smith Unveil Tea-Infused Chocolate Bar

Updated Category News Views 88

Fresh Collaborations in Portland's Culinary Scene Ah, the sweet crossover in Portland's food scene is once again in the spotlight with a new entry that's sure to titillate taste buds. Ranger Chocolate Co. and Steven Smith Teamaker are at it again, rolling out a delectable creation that merges the poetic elegance of tea with the indulgent richness of chocolate. Welcome,...

Continue Reading
Armada Moves up as Key Player in US SI Exports

Updated Category News Views 121

Pioneering New Grounds in Intelligence Infrastructure Hell of a move by Armada, stepping into the limelight as a priority team leader in the U.S. SI Exports Program. The whole gig is under the Department of Commerce's belt, pushing the frontier of America's Super Intelligence (SI) technology to buddies across the globe. It's like watching the next big blockbuster unfold...

Continue Reading
Cracking Life Insurance Needs: John Dorsa's Insights

Updated Category News Views 119

Life Insurance: A Necessary Puzzle Life’s uncertainties have a way of putting a wrench in our plans, and nothing screams uncertainty like figuring out life insurance. But fret not! HelloNation’s got insights on this financial maze, and they’ve roped in insurance pro John Dorsa from Ridgeland to help out. Calculating Coverage Needs Forget the one-size-fits-all...

Continue Reading
Veritran's Bold Move: Acquiring PrismaCampaigns Inc.

Updated Category News Views 123

Veritran's Strategic Leap Forward They're not messing around, folks. Veritran just made a power move by acquiring 100% of PrismaCampaigns Inc., and it’s more than just another day in the office. This marks a pivotal expansion of their American footprint, and they're zeroing in on our banks and credit unions with laser precision. Why This Matters for Financial...

Continue Reading
Kansai Powers Up US Grid with Bold Investment Move

Updated Category News Views 135

Betting Big on Battery Storage Let's unpack this big move by Kansai Electric. Anytime a major player like Kansai steps out of its home turf, folks better pay attention. Looks like Kansai's gotten cozy with Elevate and ArcLight, nabbing a minority stake in Prospect Power. This ain't your average widget factory—it's a beefy 150MW/600MWh battery energy storage facility in...

Continue Reading
Exploring Creation: A Fresh Look at Genesis

Updated Category News Views 88

Opening Up Genesis in a New Light Hey, if you’re like most folks, you’ve probably heard Genesis framed as the battleground for science versus religion debates, right? Enter into this mix a fresh take with Robert E. Franzen’s new book, The Narration of Creation. This book asks you to overlook those grand philosophical fights and instead focus on the narrative itself....

Continue Reading
Scientific Games Joins NCPG’s 2026 Campaign Again

Updated Category News Views 242

Scientific Games Backs Responsible Gaming Again It's another year, and here's Scientific Games once more, guns blazing for a cause that's needed more than a few times over—responsible gambling. Those folks got their hearts in the right place, joining the National Council on Problem Gambling's 2026 Gift Responsibly campaign. Ninth time running, no less! It's like...

Continue Reading
Intel Hit by Securities Law Suit Amid PC Market Struggles

Updated Category News Views 100

Intel Faces the Music: Legal Battles Unfold So it seems Intel's got itself in a kettle of fish. The tech giant is being dragged into a courtroom dance, courtesy of a class action lawsuit led by DJS Law Group. Shareholders who snapped up Intel shares between July 23 and October 29, 2026, might be scratching their heads, wondering if they bought into a bit of a mirage. A...

Continue Reading
Radnostix Sees Mixed Results, Plans Strategic Shift

Updated Category News Views 90

Radnostix: A Rocky Third Quarter with Glimmers of Hope Alright, sit back and digest this: Radnostix, the company once known as International Isotopes Inc., is currently in the midst of a renovation of sorts. They just reported their financial results for the third quarter of 2026, and honestly, they're a mixed bag. Revenue Falls but Theranostics Shines Quarterly revenue...

Continue Reading

Top 5 Most Recently Viewed Articles

Aardvark Therapeutics Advances Obesity Treatment Research

Updated Category News Views 140

Aardvark Therapeutics Unveils New Data on Obesity Treatments Aardvark Therapeutics, Inc. (AARD) recently showcased significant insights from its metabolic obesity pipeline at the latest conference dedicated to obesity, titled ObesityWeek 2025. This presentation highlighted the promising preclinical results of their innovative drug, ARD-201, which aims to enhance glucose...

Continue Reading
ITC Holdings Corp. Welcomes Carlo Capra as New VP of Engineering

Updated Category News Views 189

ITC Holdings Corp. Names Carlo Capra as Vice President of Engineering ITC Holdings Corp. has recently announced an important leadership change with the appointment of Carlo Capra as the company's new Vice President of Engineering, effective February 26, 2026. This move follows the retirement of Joe Bennett, who has played a vital role in ITC's development during his...

Continue Reading
Safeguarding Your Rights as a WEBTOON Entertainment Shareholder

Updated Category News Views 246

Understanding Your Rights as a WEBTOON Entertainment Shareholder Shareholders are urged to take action promptly, as the time to enforce your rights may be limited. Halper Sadeh LLC, an advocacy law firm focused on shareholder rights, is exploring claims regarding potential breaches of fiduciary duties by some officers and directors of WEBTOON Entertainment Inc. (NASDAQ:...

Continue Reading
TransDigm Group Delivers Strong First Quarter Performance

Updated Category News Views 124

TransDigm Group Reports First Quarter Results for Fiscal 2025 TransDigm Group Incorporated (NYSE: TDG), recognized as a leading designer, producer, and supplier of highly engineered aircraft components, recently announced their financial outcomes for the first quarter of fiscal 2025. First Quarter Financial Highlights In this first quarter, TransDigm Group achieved...

Continue Reading
Understanding Market Movements and TEM Stock Trends

Updated Category News Views 153

Market Activity Around Tempus AI In recent trading sessions, significant bearish sentiment has emerged around Tempus AI (TEM). This shift appears to be fueled by large investors taking notable positions that raise eyebrows among retail traders seeking insights on potential market movements. The Current Trading Landscape Today, we observed unusual activity in the options...

Continue Reading